{"id":6917,"date":"2025-03-03T09:31:33","date_gmt":"2025-03-03T14:31:33","guid":{"rendered":"https:\/\/www.wmfc.ca\/?p=6917"},"modified":"2025-03-03T09:31:33","modified_gmt":"2025-03-03T14:31:33","slug":"lessai-du-btk-degrader-recrute-actuellement-au-canada-2","status":"publish","type":"post","link":"https:\/\/www.wmfc.ca\/fr\/2025\/03\/03\/btk-degrader-trial-now-recruiting-in-canada-2\/","title":{"rendered":"Recrutement actif pour un essai clinique sur le d\u00e9gradeur de KTB (\"BTK\")  au Canada"},"content":{"rendered":"<p>L'essai clinique NCT05006716 portant sur le BGB-16673 de Beigene, un d\u00e9sint\u00e9grateur de prot\u00e9ines ciblant la tyrosine kinase de Bruton, recrute des patients \u00e0 Calgary, Edmonton, Qu\u00e9bec, Vancouver et Toronto.    Titre officiel de l'\u00e9tude : <em>\u00c9tude de phase 1\/2, ouverte, d'escalade de dose et d'expansion du BGB-16673, un d\u00e9gradeur de prot\u00e9ines ciblant les tyrosines kinases de Bruton, chez des patients atteints d'une tumeur maligne \u00e0 cellules B.<\/em>.  Pour plus d'informations, voir la rubrique <a href=\"https:\/\/clinicaltrials.gov\/study\/NCT05006716\" target=\"_blank\" rel=\"noopener\">Description de l'essai sur le site des NIH<\/a>.<\/p>","protected":false},"excerpt":{"rendered":"<p>L'essai clinique NCT05006716 portant sur le BGB-16673 de Beigene, un d\u00e9sint\u00e9grateur de prot\u00e9ines ciblant la tyrosine kinase de Bruton, recrute des patients \u00e0 Calgary, Edmonton, Qu\u00e9bec, Vancouver et Toronto.    Titre officiel de l'\u00e9tude : \u00c9tude de phase 1\/2, ouverte, d'escalade de dose et d'expansion du Bruton Tyrosine Kinases Targeted Protein Degrader BGB-16673 chez des patients atteints de tumeurs malignes \u00e0 cellules B.  Pour plus d'informations, voir la description de l'essai sur le site web des NIH.<\/p>","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_price":"","_stock":"","_tribe_ticket_header":"","_tribe_default_ticket_provider":"","_ticket_start_date":"","_ticket_end_date":"","_tribe_ticket_show_description":"","_tribe_ticket_show_not_going":false,"_tribe_ticket_use_global_stock":"","_tribe_ticket_global_stock_level":"","_global_stock_mode":"","_global_stock_cap":"","_tribe_rsvp_for_event":"","_tribe_ticket_going_count":"","_tribe_ticket_not_going_count":"","_tribe_tickets_list":"[]","_tribe_ticket_has_attendee_info_fields":false,"footnotes":""},"categories":[26],"tags":[],"class_list":["post-6917","post","type-post","status-publish","format-standard","hentry","category-physician-info"],"_links":{"self":[{"href":"https:\/\/www.wmfc.ca\/fr\/wp-json\/wp\/v2\/posts\/6917","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.wmfc.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.wmfc.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.wmfc.ca\/fr\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.wmfc.ca\/fr\/wp-json\/wp\/v2\/comments?post=6917"}],"version-history":[{"count":2,"href":"https:\/\/www.wmfc.ca\/fr\/wp-json\/wp\/v2\/posts\/6917\/revisions"}],"predecessor-version":[{"id":6919,"href":"https:\/\/www.wmfc.ca\/fr\/wp-json\/wp\/v2\/posts\/6917\/revisions\/6919"}],"wp:attachment":[{"href":"https:\/\/www.wmfc.ca\/fr\/wp-json\/wp\/v2\/media?parent=6917"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.wmfc.ca\/fr\/wp-json\/wp\/v2\/categories?post=6917"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.wmfc.ca\/fr\/wp-json\/wp\/v2\/tags?post=6917"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}